The story
Macedonia’s 2016 amendment opened a corporate route to growing cannabis for medical and scientific purposes. Published in Gazette 37 on 26 February, it took effect on the eighth day after publication, 5 March. The new framework placed approvals, planting and harvest records under several public authorities.[1][2]
Companies needed two stages of permission
The health ministry could approve a grower only after obtaining the government’s consent. Before sowing or planting, the company also had to apply to the agriculture ministry, supplying the growing approval and its approved cultivation plan.[1]
This was a route for legal entities rather than an individual patient’s home crop. The company had to notify the relevant authorities before planting, and inspectors checked the crop during its development. The law linked the permission to a documented production process.[1]
The framework followed the crop through harvest
Growers had to record sowing, seedlings, transplanting and plant numbers. Changes from the approved plan had to be reported, and the authorities had to be told before harvest. A commission checked the harvested stems and wet weight.[1]
The crop then had to dry in a dedicated space at the cultivation site. Dried material was packed, sealed and labelled with the producer, production year, material form and weight. A further report recorded the final dry weight. These requirements sought to connect the authorised crop to the material leaving production.[1]
Production grew faster than domestic access
A 2025 market review reported sixty-six cultivation and production licences issued by 2022, while noting that only some operators had achieved commercial output or export certification. Its account described a substantial production industry alongside restricted domestic patient access.[3]
Patients depended on specialist-prescribed products and dispensing pharmacies. The report identified few pharmacies able to supply them and no public reimbursement, leaving patients to pay the treatment cost. A licence count therefore did not measure how many people could obtain treatment.[3]
Later inspections tested the controls
On 7 February 2026, the Interior Ministry described quantity and documentation discrepancies found during checks at cannabis businesses. It reported about nine tonnes of marijuana and more than thirteen hundred bottles of semi-finished oil seized in Skopje, alongside over thirty-one tonnes of marijuana and biomass in the east.[4]
Those were materials seized during an investigation, rather than proof that every licensed operator diverted cannabis. The North Macedonia profile records the medical framework separately from those enforcement cases and from the later personal-possession exemption.[1][4]
Score by segment 0 to 10
- Possession · 25%1 → 1
- Personal cultivation · 25%1 → 1
- Punishment & enforcement · 20%2 → 2
- Sharing & gifting · 10%1 → 1
- Consumption · 10%1 → 1
- Legal access · 10%0 → 1+1
The bar shows the score after the change; the tick marks where it stood before. North Macedonia's scores have changed again since.
References
- MALMED — Drug Control Law, consolidated through Gazette 193/2017Articles 29-a–29-f; transitional clauses for Gazette 37/2016archived
- Justice Ministry database — Drug-control amendments and publication datesRelated laws, Gazette 37 published 26 February 2016archived
- Prohibition Partners — North Macedonia medical market overview2 October 2025, licensing and patient accessarchived
- Interior Ministry — Cannabis seizures update, 7 February 2026Skopje and eastern-region inspectionsarchived
Checked. The date and the event were compared with a source that was read. The score before the change is an editorial estimate.